The quality of the information in the Summary of the Product Characteristics
The Summary of the Product Characteristics (SPC) represents the source of official and legitimate drug information for the healthcare professionals within the European Union. Specific information concerning the use in pregnancy, breastfeeding and fertile age, besides the effects on fertility, are described in a special section of the SPC, whose content is established by the European Commission for the drugs authorised by centralised procedure.1